Lafayette Instrument Acquires Alzet Osmotic Pumps from DURECT

November 25, 2024

Lafayette Instrument, a Branford Castle Partners portfolio company, has acquired the ALZET Osmotic Pumps business from DURECT Corporation as an add-on to expand Lafayette’s life-science instrumentation offering. The acquisition strengthens Lafayette’s preclinical dosing product line and represents the fourth bolt-on for the company since Branford Castle’s 2021 investment; the deal includes senior and mezzanine debt financing.

Targets
ALZET Osmotic Pumps (business unit of DURECT Corporation)
Sellers
DURECT Corporation
Platforms
Lafayette Instrument
Industry
Medical Devices
Location
California, United States
Transaction Type
Addon

Explore More

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.